文献速递乳腺MRUS乳腺X线

术前MRI评估提高乳腺导管原位癌保乳手术率但不影响局部疾病控制

Preoperative magnetic resonance imaging evaluation improves breast conserving surgery rate but not local disease control in patients with ductal carcinoma in situ.
PubMed 文献 · Eur J Radiol · 2026-04-03

该回顾性研究纳入两个乳腺中心2009至2021年1351例导管原位癌患者,比较术前MRI与非MRI队列的手术方式及局部复发。MRI测量病灶最大径与病理相关性优于超声和乳腺X线,且准确率更高。倾向性评分匹配后MRI组保乳手术率更高(28.6% vs 19.1%),但初始切缘阴性率、二次全乳切除率及局部复发率无差异。

要点

  • MRI测量DCIS最大径与病理相关性(ρ=0.657)优于超声(ρ=0.574)。
  • MRI测量准确率51.3%,高于乳腺X线32.5%和超声45.0%。
  • 术前MRI与更高保乳手术率相关,但不改善局部疾病控制。

核心结论

  • 术前MRI可准确测量DCIS病灶,与更高保乳手术率相关,但未影响局部疾病控制。

研究设计与样本

  • 回顾性队列研究,纳入两个乳腺中心2009至2021年1351例接受初次手术的DCIS患者,分为MRI和非MRI队列,并进行倾向性评分匹配。

诊断标准与关键数值

  • MRI与病理最大径测量总体相关性ρ=0.657,超声与病理ρ=0.574(P<0.001)。
  • MRI测量准确率51.3%,高于乳腺X线32.5%(P<0.001)和超声45.0%(P=0.033)。
  • 倾向性评分匹配后MRI组保乳手术率28.6%,非MRI组19.1%(P=0.003)。
  • 计划保乳的227例患者中,MRI组和非MRI组初始切缘阴性率分别为73.6%和71.9%(P=0.485)。
  • 两组二次全乳切除率分别为22.0%和23.7%(P=0.433),局部复发率相似。

临床应用与阅片要点

  • 术前MRI可用于DCIS病灶范围评估,辅助手术方式选择,尤其计划保乳时。
  • 需注意MRI可能高估或低估病灶,测量准确率仅约51.3%,应结合乳腺X线和超声综合判断。

局限性

  • 回顾性研究设计,仅纳入两个中心,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The role of preoperative evaluation by magnetic resonance imaging (MRI) in breast ductal carcinoma in situ (DCIS) management remains controversial. The study aims to evaluate the impact of preoperative MRI on surgery type and local disease control in DCIS patients.

METHODS: Patients with DCIS who received primary surgery between 2009 and 2021 in two breast centers were retrospectively included and subdivided into MRI and non-MRI cohorts. The largest diameters (LD) of target lesion measured on mammography, ultrasound, MRI, and histopathology were compared. Associations between preoperative MRI, clinicopathological characteristics, surgery type, and local recurrence were evaluated after propensity score matching (PSM).

RESULTS: A total of 1351 patients were included. The mean of LD measurements from histopathology, ultrasound, mammography, and MRI was 19.6 ± 14.0 mm, 21.7 ± 13.0 mm, 14.4 ± 14.3 mm, and 21.9 ± 13.9 mm, respectively. The overall correlation for LD measurements between MRI and histopathology (ρ = 0.657) was stronger than that between ultrasound and histopathology (ρ = 0.574; P < 0.001). LD measurements were significantly more accurate measured by MRI (51.3%) than by mammography (32.5%; P < 0.001) and ultrasound (45.0%; P = 0.033) compared with histopathology . After PSM for clinicopathological factors, patients in MRI cohort were more likely to receive breast conserving surgery (BCS) than those in non-MRI cohort (28.6% vs. 19.1%; P = 0.003). For 227 patients planning to receive BCS as primary surgery, initial negative surgical margin was similar between MRI and non-MRI cohorts (73.6% vs. 71.9%; P = 0.485). There was no difference in secondary mastectomy rate between two cohorts (22.0% vs. 23.7%; P = 0.433). Patients in two cohorts have similar local recurrence rates.

CONCLUSION: Preoperative MRI evaluation could provide accurate measurement for DCIS lesion, and was associated with a higher BCS rate in DCIS patients but did not impact local disease control.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Zhang X, Zhu X, et al. Preoperative magnetic resonance imaging evaluation improves breast conserving surgery rate but not local disease control in patients with ductal carcinoma in situ. Eur J Radiol. 2026. PMID: 41974155. doi:10.1016/j.ejrad.2026.112842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。